Rutherford House
Stephensons Way
Leicester, Leicestershire DE21 6LY
Phone: 4403542600
www.steris.com
STERIS plc (NYSE:STE) concluded the trading at $177.50 on Friday, March 10 with a fall of -2.75% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $182.52 with its price kept floating in the range of $176.72 and $182.515 on the day. … STERIS plc (STE) Forecast: Revisiting The Past To Gain Insights For The Future Read More »
The Global Sterilization Equipment Market Size was valued at USD 7.1 billion in 2021 and the worldwide sterilization equipment market size is expected to reach USD 15.3 billion by 2030, according to a research report published by Spherical Insights & Consulting. Covered Key players STERIS, Getinge AB, Sotera Health, Fortive, 3M, Cardinal Health, Metall Zug Group, Stryker Corporation, Merck KGaA, MMM Group, MATACHANA GROUP, Tuttnauer, Andersen Sterilizers, Steelco S.p.A., Noxilizer, DE LAMA S.P.A., Cosmed Group, C.B.M. S.r.l. Medical Equipment, E-BEAM Services, Inc., Life Science Outsourcing, Inc., Systec GmbH, Continental Equipment Company and among others. The Global Sterilization Equipment Market Size was valued at USD 7.1 billion in 2021 and the worldwide sterilization equipment market size is expected to reach USD 15.3 billion by 2030, according to a research report published by Spherical Insights & Consulting. Covered Key players STERIS, Getinge AB, Sotera Health, Fortive, 3M, Cardinal Health, Metall Zug Group, Stryker Corporation, Merck KGaA, MMM Group, MATACHANA GROUP, Tuttnauer, Andersen Sterilizers, Steelco S.p.A., Noxilizer, DE LAMA S.P.A., Cosmed Group, C.B.M.
STERIS plc (Ireland) - Consensus Indicates Potential 14.8% Upside
Newark, New Castle, USA Infection Control Market Analysis 2022 | by Product (Sterilization, Disinfection, Endoscope Reprocessing, Protective Barriers), End User (Hospitals & Clinics, Pharmaceutical & Medical Device Companies) Business Opportunities, Pricing Strategy, Forthcoming opportunities planning, Market-specific challenges, Globally Market Key
Trading Steris Plc STE With Integrated Risk Controls
A big earnings miss turned investors off, as did reduced guidance.
https://www.investing.com/news/pro/steris-pt-lowered-to-215-at-piper-sandler-432SI-3000455
STERIS plc (NYSE:NYSE:STE) Q3 2023 Earnings Conference Call February 9, 2023 10:00 AM ETCompany ParticipantsJulie Winter - IRDaniel Carestio - President and CEOMichael Tokich - SVP and…
Steris (STE) is trading ~10% lower after the company missed profit, revenue estimates and lowered 2023 profit guidance that were below Wall Street consensus.Healthcare revenue grew 1%…
Steris Plc (STE) shares closed today 10.9% lower than it did at the end of yesterday. The stock is currently up 16.9% year-to-date, down 5.8% over the past 12 months, and up 168.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.7%, and the S&P 500 fell 0.9%. Trading Activity Shares traded as high as $221.90 and as low as $211.21 this week.Shares closed 24.5% below its 52-week high and 21.2% above its 52-week low.Trading volume this week was 3.8% lower than the 10-day average and 10.2% higher than the 30-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index today, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 64.0% The company's stock price performance over the past 12 months beats the peer average by -71.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
WASHINGTON (dpa-AFX) - STERIS plc (STE) reported a profit for third quarter that decreased from last year and missed the Street estimates.The company''s bottom line totaled $123.83 million, or $1.2…
DUBLIN (AP) — DUBLIN (AP) — Steris Corp. (STE) on Wednesday reported profit of $123.8 million in its fiscal third…
Steris press release (STE): Q3 Non-GAAP EPS of $2.02 misses by $0.17.Revenue of $1.22B (+1.7% Y/Y) misses by $50M.As reported revenue is now anticipated to grow 6% compared with…
DUBLIN, IRELAND, Feb. 08, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 third quarter ended December 31, 2022. Revenue as reported for the quarter increased 1% to $1.22 billion compared with $1.21 billion in the third quarter of fiscal 2022. Constant currency organic revenue (see Non-GAAP Financial Measures) increased 7% for the third quarter of fiscal 2023 as compared to the third quarter of fiscal 2022.
Steris (NYSE: STE ) is set to give its latest quarterly earnings report on Wednesday, 2023-02-08. Here''s what investors need to know before the announcement. Analysts estimate that Steris will report an earnings per share (EPS) of $2.19. Steris bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next … Full story available on Benzinga.com
Steris has caught a tremendous bid off its 52-week lows after a Court ruled in favour of its competitor, Sotera. Read why we are re-rating STE stock.
Low Temperature Sterilization Equipment Market Size Projections : The global Low Temperature Sterilization Equipment Market was valued at US$ 1,120.1 million in 2022 and is expected to witness a robust CAGR of 10.6% over the forecast period (2023 - 2030). The